
Home » Teva $1 Billion Market Depends on New Test of Laquinimod
Teva $1 Billion Market Depends on New Test of Laquinimod
August 27, 2012
Teva Pharmaceutical is recruiting about 1,800 patients for a new trial of its multiple sclerosis pill in a bid to improve how the disease is treated and secure a successor to its best-selling medicine.
Businessweek
Businessweek
Upcoming Events
-
19Jan
-
21Jan
-
26Jan
-
27Jan
-
27Jan
-
09Feb